All Posts:Vaccine
-
H5 Influenza Vaccines: What Needs To Be Done To Reduce the Risk of a Pandemic
As the global threat of H5N1 influenza looms, with outbreaks across species and continents, including the U.S., three international vaccine and public health experts say it is time to fully resource and support a robust strategy to address this and future potential pandemic influenza threats, including to consider voluntary vaccination for those now at exposure risk.
Category: News Release
-
Statement from Jesse L. Goodman, MD, MPH, on FDA Approval of Pfizer-BioNTech’s COVID-19 Vaccine
WASHINGTON (August 23, 2021) — Today, the U.S. Food & Drug Administration approved the two-dose COVID-19 Pfizer-BioNTech vaccine. Jesse L. Goodman, MD, MPH, professor of medicine and infectious diseases at Georgetown University Medical Center and former FDA Chief Scientist, shares the following comments: “In addition to evaluating the vaccine’s safety and efficacy in preventing COVID, FDA has […]
Category: News Release
-
Georgetown’s Jesse Goodman Leads Vaccine Analysis Team
(May 7, 2021) — If you’ve read news stories this past year about COVID-19 vaccines in The Washington Post or The New York Times, for example, or have heard stories on NPR, the journalists’ reporting may well have been informed by input from a group of vaccine experts led by Georgetown infectious disease specialist Jesse […]
Category: GUMC Stories
-
Clinical Students Volunteer With COVID-19 Vaccinations
(February 19, 2021) — Since mid-January, more than 150 medical and nursing students at Georgetown have answered MedStar Health’s call for volunteers to administer the COVID-19 vaccine. Coordinated by Elizabeth Zolper (M’21), the students volunteer every day of the week at four MedStar Health locations around Washington, D.C. Throughout this pandemic, students have contributed to […]
Category: GUMC Stories